Ahmad K, Baig MH, Gupta GK et al (2016) Identification of common therapeutic targets for selected neurodegenerative disorders: an in silico approach. J Comput Sci 17:292–306. https://doi.org/10.1016/j.jocs.2016.03.007
Alecu I, Bennett SA (2019) Dysregulated lipid metabolism and its role in α-synucleinopathy in Parkinson’s disease. Front Neurosci 13:328. https://doi.org/10.3389/fnins.2019.00328
Article PubMed PubMed Central Google Scholar
Anjum R (2025) Neuroprotective role of traditional Chinese plant extracts on Parkinson’s disease; a comprehensive preclinical review. Pharmacol Res-Mod Chin Med 14:100573. https://doi.org/10.1016/j.prmcm.2025.100573
Arafah A, Khatoon S, Rasool I et al (2023) The future of precision medicine in the cure of Alzheimer’s disease. Biomedicines 11:335. https://doi.org/10.3390/biomedicines11020335
Article CAS PubMed PubMed Central Google Scholar
Arias N, Panuccio G, Rothermel M (2023) Editorial: New challenges and future perspectives in cellular neuroscience. Front Cell Neurosci 17:1136888. https://doi.org/10.3389/fncel.2023.1136888
Article PubMed PubMed Central Google Scholar
Asthana S, Shukla V, Tripathi A (2023) In vivo models for evaluation of drug efficacy: demand and challenges. In: Drugs and a methodological compendium: from bench to bedside. Springer Nature Singapore, Singapore, pp 113–147. https://doi.org/10.1007/978-981-19-7952-1_5
Awasthi M, Singh S, Pandey VP, Dwivedi UN (2016) Alzheimer’s disease: an overview of amyloid beta dependent pathogenesis and its therapeutic implications along with in silico approaches emphasizing the role of natural products. J Neurol Sci 361:256–271. https://doi.org/10.1016/j.jns.2016.01.008
Article CAS PubMed Google Scholar
Baker M, Hong SI, Kang S, Choi DS (2020) Rodent models for psychiatric disorders: problems and promises. Lab Anim Res 36:9. https://doi.org/10.1186/s42826-02000039-z
Article PubMed PubMed Central Google Scholar
Banik A, Brown RE, Bamburg J et al (2015) Translation of pre-clinical studies into successful clinical trials for Alzheimer’s disease: what are the roadblocks and how can they be overcome? J Alzheimers Dis 47:815–843. https://doi.org/10.3233/JAD-150136
Barlow DJ, Buriani A, Ehrman T et al (2012) Insilico studies in Chinese herbal medicines’ research: evaluation of in-silico methodologies and phytochemical data sources, and a review of research to date. J Ethnopharmacol 140(3):526–534. https://doi.org/10.1016/j.jep.2012.01.041
Article CAS PubMed PubMed Central Google Scholar
Barman NC (2020) CRISPR-Cas9: a promising genome editing therapeutic tool for Alzheimer’s disease—a narrative review. Neurol Ther 9:419–434. https://doi.org/10.1007/s40120-020-00218-z
Article PubMed PubMed Central Google Scholar
Bassil K, Horstkötter D (2023) Ethical implications in making use of human cerebral organoids for investigating stress—related mechanisms and disorders. Cambridge Q Healthc Ethics 32:529–541. https://doi.org/10.1017/S0963180123000038
Bertapelle C, Polese G, Cosmo A (2017) Enriched environment increases PCNA and PARP1 levels in Octopus vulgaris central nervous system: first evidence of adult neurogenesis in Lophotrochozoa. J Exp Zool B Mol Dev Evol 328:347–359. https://doi.org/10.1002/jez.b.22735
Article CAS PubMed Google Scholar
Białkowska K, Komorowski P, Bryszewska M, Miłowska K (2020) Spheroids as a type of three-dimensional cell cultures—examples of methods of preparation and the most important application. Int J Mol Sci 21:6225. https://doi.org/10.3390/ijms21176225
Article CAS PubMed PubMed Central Google Scholar
Bowen A, Casadevall A (2015) Increasing disparities between resource inputs and outcomes, as measured by certain health deliverables in biomedical research. Proc Natl Acad Sci U S A 112:11335–11340. https://doi.org/10.1073/pnas.1504955112
Article CAS PubMed PubMed Central Google Scholar
Cai H, Chen MY, Li XH, Zhang L, Su Z, Cheung T, Tang YL, Malgaroli M, Jackson T, Zhang Q, Xiang YT (2024) A network model of depressive and anxiety symptoms: a statistical evaluation. Mol Psychiatry 29:767–781. https://doi.org/10.1038/s41380-023-02369-5
Article PubMed PubMed Central Google Scholar
Chaoul V, Dib E-Y, Bedran J et al (2023) Assessing drug administration techniques in zebrafish models of neurological disease. Int J Mol Sci 24:14898. https://doi.org/10.3390/ijms241914898
Article CAS PubMed PubMed Central Google Scholar
Charles L. Nunn, David R. Samson (2018) Sleep in a comparative context: investigating how human sleep differs from sleep in other primates - Nunn - 2018 - American Journal of Physical Anthropology - Wiley Online Library. https://doi.org/10.1002/ajpa.23427. Accessed 9 Aug 2025.
Chen et al (2017) Modeling Rett syndrome using TALEN-edited MECP2 mutant cynomolgus monkeys. Cell. https://doi.org/10.1016/j.cell.2017.04.035. https://www.cell.com/cell/fulltext/S0092-8674(17)30489-0?dgcid=cell.com-slider_referral_cell-slider-Chen. Accessed 9 Aug 2025
Chen N, Liu C, Yan N, Hu W, Zhang JG, Ge Y, Meng FG (2013) A macaque model of mesial temporal lobe epilepsy induced by unilateral intrahippocampal injection of Kainic acid. PloS One 8:e72336. https://doi.org/10.1371/journal.pone.0072336
Article CAS PubMed PubMed Central Google Scholar
Chia K, Klingseisen A, Sieger D, Priller J (2022) Zebrafish as a model organism for neurodegenerative disease. Front Mol Neurosci 5:940484. https://doi.org/10.3389/fnmol.2022.940484
Choi SH, Kim YH, Quinti L et al (2016) 3D culture models of Alzheimer’s disease: a road map to a “cure-in-a-dish.” Mol Neurodegener 11:75. https://doi.org/10.1186/s13024-016-0139-7
Article CAS PubMed PubMed Central Google Scholar
Correll CU, Schooler NR (2020) Negative symptoms in schizophrenia: a review and clinical guide for recognition, assessment, and treatment. Neuropsychiatr Dis Treat 16:519–534. https://doi.org/10.2147/NDT.S225643
Article PubMed PubMed Central Google Scholar
Cosmo A, Pinelli C, Scandurra A et al (2021) Research trends in octopus biological studies. Animals (Basel) 11:1808. https://doi.org/10.3390/ani11061808
Costa FV, Rosa LV, Quadros VA et al (2022) The use of zebrafish as a non-traditional model organism in translational pain research: the knowns and the unknowns. Curr Neuropharmacol 20:476–493. https://doi.org/10.2174/1570159X19666210311104408
Article CAS PubMed PubMed Central Google Scholar
Coukos Robert, Krainc Dimitri (2024) Key genes and convergent pathogenic mechanisms in Parkinson disease | Nature Reviews Neuroscience. https://www.nature.com/articles/s41583-024-00812-2. Accessed 9 Aug 2025
Csobonyeiova M, Polak S, Danisovic L (2020) Recent overview of the use of IPSCS Huntington’s disease modeling and therapy. Int J Mol Sci 21:2239. https://doi.org/10.3390/ijms21062239
Article CAS PubMed PubMed Central Google Scholar
Cruz-Vicente P, Passarinha LA, Silvestre S, Gallardo E (2021) Recent developments in new therapeutic agents against Alzheimer and Parkinson diseases: in-silico approaches. Molecules 26:2193. https://doi.org/10.3390/molecules26082193
Article CAS PubMed PubMed Central Google Scholar
Dawson TM, Golde TE, Lagier-Tourenne C (2018) Animal models of neurodegenerative diseases. Nat Neurosci 21:1370–1379. https://doi.org/10.1038/s41593-018-0236-8
Article CAS PubMed PubMed Central Google Scholar
Deakin AG, Buckley J, AlZu’bi HS et al (2019) Automated monitoring of behaviourinzebrafish after invasive procedures. Sci Rep 9:9042. https://doi.org/10.1038/s41598019-45464-w
Devi A, Dwibedi V, Khan ZA (2021) Natural antioxidants in new age-related diseases. Rev Bras Farmacogn 31:387–407. https://doi.org/10.1007/s43450-021-00175-0
Dr Ahmad W, Dr Shabbiri K, Ahmad I (2020) Prediction of human tau 3D structure, and interplay between O-β-GlcNAc and phosphorylation modifications in Alzheimer’s disease: C. elegans as a suitable model to study these interactions in vivo. Biochem Biophys Res Commun 528:466–472. https://doi.org/10.1016/j.bbrc.2020.05.176
Eaton SL, Wishart TM (2017) Bridging the gap: large animal models in neurodegenerative research. Mamm Genome 28:324–337.
Comments (0)